LIVER - NON HEPATITIS & Cannabis studies completed
Like any other medicinal plant, cannabis has intrinsic properties that allow it to produce both beneficial effects and undesired side effects.
Some of these side effects are cognitive, such as the impairment of the short-term memory or the potential to trigger psychotic episodes in susceptible individuals. (Sensi Seeds published an interesting article on Cannabis and Episodic Memory. To read it click here, ed)
The negative physical side effects of cannabis include an increase in oxygen consumption by the heart tissues and, as we shall see in this article, the capacity to accelerate the progression of fibrosis in individuals suffering chronic Hepatitis C, if cannabis is consumed regularly and not just on a sporadic basis.
In cirrhotic human livers, there is a higher number of CB1 Cannabinoid receptors, which indicates that the Endocannabinoid system is involved in the physiopathology of this clinical picture. (You can read more about the Cannabinoid Science and the Endocannabinoid System here, ed)
Science and Research
2011 - Study ~ Endocannabinoids in liver disease.
2009 - Study ~ Cannabinoids as novel anti-inflammatory drugs.
2008 - Study ~ CB2 receptors as new therapeutic targets for liver diseases.
2008 - Study ~ Role of cannabinoids in chronic liver diseases
2008 - Study ~ Endocannabinoids and the Control of Energy Homeostasis
2007 - Study ~ CB2 receptors as new therapeutic targets for liver diseases
2005 - Study ~ The endocannabinoid system in chronic liver disease
2005 - Study ~ (Marijuana/Hash) Endocannabinoids and liver disease - review
2004 - Study ~ Treatment of the Pruritus of Cholestasis2003 - Study ~ Pathogenesis and treatment of pruritus in patients with cholestasis